Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
36
NCT03840512
An Open Label Study of Multiple Doses of Cannabidiol in the Prevention of Acute Graft-Versus-Host Disease (GVHD)
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 12, 2018
Completion: Dec 15, 2022